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Summary
Objectives: To report the lessons learned from eight
years of feeding back routinely collected cardiovascular
data in an educational context
Methods: There are distinct educational and technical
components. The educational component provides
peer-led learning opportunities based on comparative
analysis of quality of care, as represented in computer
records. The technical part ensures that relevant
evidence-based audit criteria are identified; an appro-
priate dataset is extracted and processed to facilitate
quality improvement. Anonymised data are used
to provide inter-practice comparisons, with lists of
identifiable patients who need interventions left in
individual practices.
Results: The progressive improvement in cholesterol
management in ischaemic heart disease (IHD) is used
as an exemplar of the changes achieved. Over three
iterations of the cardiovascular programme the stan-
dardised prevalence of IHD recorded in GP computer
systems rose from 3.8% to 4.0%. Cholesterol recording
rose from 47.6% to 89.0%; and the mean cholesterol
level fell from 5.18 to 4.67 mmol/L; while statin pre-
scribing rose from 46% to 57% to 68%. The atrial
fibrillation, heart failure and renal programmes (more
people with chronic kidney disease go on to die from
cardiovascular cause than from end-stage renal dis-
ease) are used to demonstrate the range of cardio-
vascular interventions amenable to this approach.
Conclusions: Technical progress has meant that larger
datasets can be extracted and processed. Feedback of
routinely collected data in an educational context is ac-
ceptable to practitioners and results in quality improve-
ment. Further research is needed to assess its utility
as a strategy and cost-effectiveness compared with
other methods.
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Introduction
UK general practice is computerised and
quality targets based on computer data pro-
vide incentives to improve data quality [1].
Despite this, routinely collected data is an
underused resource and there remains scope
to further improve computer data quality
[3-5]. Our approach to quality improvement
is to use an educational intervention based
on feedback of routinely collected data and
what it says about the quality of care [6-9].
We use a range of methods of feedback to
provide a range of learning opportunities to
match the likely range of learning styles of
primary care professionals. It incorporates
the use of: the theory of diffusion of inno-
vations [10, 11], academic detailing [12],
adult learning theory [13] and what are
known to be effective methods of feedback
[14].
Cardiovascular (CVS) disease is an im-
portant cause of morbidity and mortality
worldwide and has been the principal area
within which our intervention has been
tested. There is a range of evidence-based
interventions available to primary care,
which can make a difference to outcome.
These include: improving cholesterol man-
agement in patients with ischaemic heart
disease [15], monitoring high-risk patients
with atrial fibrillation (AF) receiving anti-
coagulant therapy [16] and tackling cardio-
vascular risk in people with chronic kidney
disease (CKD), much of which is under
treated [17]. Many more people with CKD
suffer preventable cardiovascular disease
than go on to end-stage renal disease [18].
This paper reports the lessons from over
eight years of working with general practice
data and feeding it back, in an educational
context, to improve the quality of care. Im-
proved cholesterol management in isch-
aemic heart disease (IHD) and using com-
puter searches to identify suboptimally
managed cardiovascular risk, people with
AF [9] and CKD [19] are used as exemplars
of the practical application of this work.
Methods
The method used in the Primary Care Data
Quality (PCDQ) programme has two com-
ponents: design of an educational interven-
tion and a technical process (see Fig 1).
The design of the educational interven-
tion provides clinically relevant feedback to
clinicians and overview statistics to local
health service managers and researchers.
We design separate interventions for each
clinical area we work in, looking to provide
an innovative way that evidence care might
be improved. We look to work with opinion
leaders within a locality, to influence those
likely to be early adopters of change [10, 11]
and, where appropriate, support the imple-
mentation of evidence-based national tar-
gets. Carefully designed academic detailing
supports each clinical programme, we keep
the volume of data fed back brief with an
educational focus [12]. A different visual
appearance is adopted for each variable and
a gentle sense of competition is created by
comparing the performance of each practice
[13]. The programmes are run in a non-
judgemental learning environment, which
seeks to follow a learner-centred shared
problem-solving orientation. Wherever pos-
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sible this takes place in protected learning
time at locally led, half-day, data quality
workshops (DQW). The programmes are
implemented in areas where there is clinical
need, an evidence-base and interventions to
improve quality [14]. The feedback process
has been designed and developed to in-
crease its chances of success.
The Data Quality Workshop (DQW) is
also supported by other interventions. We
provide graphical summaries of data to each
practice, indicating how their data quality
compares with their peers, a summary
spreadsheet of practice data quality sent to
the local primary care organisation, with the
consent of the practices and Field staff pro-
vide basic one-to-one Read code training
for primary care professionals, if needed.
We also invite each locality where the pro-
gramme operates to the annual PCDQ
Forum. This is a two-day action research
workshop where we ask for comments on
the strengths and weaknesses of the pro-
gramme and plan future developments ac-
cordingly.
3) Data extraction: We routinely use
MIQUEST [23] (Morbidity Information
Query and Export Syntax – a Depart-
ment of Health sponsored data extraction
tool) to take out data from general prac-
tice systems.
4) Migration: Data is usually extracted
using a physical transfer medium, e.g.
floppy disk and migrated into a format
whereby it can be integrated into the data
repository.
5) Integration: Different data tables, data
about subsets of patients with one dis-
ease, serial data collections all have to be
linked, so that the project outputs can be
delivered. We also de-duplicate at this
stage.
6) Cleaning: Here the issue of out of range
values, inconsistencies such as data
entry in more than one type of unit
(e.g. heights in centimetres and metres)
and other problems with the data are ad-
dressed.
7) Processing: Processing involves the con-
version of extracted code into the plain
English text assigned to that code by the
coding system; e.g. the code H3z into
“chronic obstructive pulmonary dis-
ease”. It involves grouping these into cat-
egories relevant to the intended analysis.
8) Analysis:The output from the processing
stage is usually a “flat file”. This will
have one line per patient data and vari-
ables in columns. The first stage is to as-
sess the quality of the data (complete-
ness, accuracy, consistency, currency)
[24] and where appropriate to calculate
the sensitivity and positive predictive
value of diagnostic and prescribing data
[4]. Automated reports are generated
from this data for feedback to practices
or localities or flat-file data tables for
research, which are migrated into a
standard statistical package.
Results
Results from a range of clinical areas are
presented to demonstrate the generaliseabil-
ity of our method. These are the manage-
ment of cholesterol in IHD, preventing
stroke in atrial fibrillation (AF) and reduc-
The technical process [20] is based on tax-
onomy for error reduction developed in the
context of quality assurance of the healthcare
data warehouse [21]. Successful or good
quality output is defined using the definition
of data quality used in total data quality man-
agement (TQDM) as data fit for purpose by
its consumers [22]: i.e. in our case, data use-
able as an educational intervention to improve
chronic disease management, to improve the
health of populations and for research.
1) Design phase: This consists of four
steps, refining the research question and
then identifying the dataset available to
answer it. We then explore any research
or information governance and data pro-
tection issues. Finally, test data is ex-
tracted and processed and the lessons
fed back into the design process.
2) Data entry issues: Our methodological
approach takes account of data entry is-
sues as they can have a profound effect
on the way that patients with the same
clinical conditions are represented with-
in the computer system.
Fig. 1 The PCDQ educational and technical processes
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ing cardiovascular risk in patients with un-
detected chronic kidney disease (CKD).
The programmes in AF and CKD dif-
fered from the IHD programme in that we
stratified risk by processing data outside the
GP computer system. Most GPs and prac-
tice nurses are familiar with estimating risk
in IHD using the appropriate risk factors
and are often assisted by their computer sys-
tem in performing these calculations. In the
AF and CKD programmes, we used stan-
dard algorithms to calculate and stratify risk
outside the computer system. This meant
not only did we have to feedback these data
and what they said about the quality of care,
but we also had to explain how we had cal-
culated risk. In AF, although we found an in-
crease in prevalence of the disease, most of
the patients were already identified in the
GP computer records and practitioners were
aware of the evidence-base. In CKD we
identified that 5% of practice populations
have decline in kidney function and that the
practices are neither aware of this condition
or the evidence-base for interventions to im-
prove cardiovascular risk. The increasing
complexity of the educational challenge in
these three programmes is set out inTable 1.
Practices participating in the PCDQ car-
diovascular programme have progressively
improved their management of cholesterol.
More patients are diagnosed with IHD,
more have their cholesterol measured and a
greater proportion are treated with choles-
terol-lowering therapy and achieve the tar-
get set for cholesterol lowering. Practi-
atrial fibrillation was 1.23% (1.28% for men
and 1.18% for women). 46% of men and
37% of women were prescribed Warfarin or
had contraindications to its use. The lower
proportion of women being treated is statis-
tically significant (Chi-square p <0.001).
Of the people with AF prescribed Warfarin
only three-quarters (75.9%) have an INR
(International Normalised Ratio) in range.
44% were treated with aspirin. People at
high risk of stroke were no more likely to be
treated with Warfarin or aspirin than those at
moderate risk and care of females was sub-
optimal compared with males. These find-
ings were challenging for GP colleagues,
who were generally aware of the evidence
but were not implementing it within their
practices [30].
Our investigation of the quality of care in
chronic kidney disease (CKD) revealed that
this condition was largely undiagnosed and
there was scope to improve the management
of cardiovascular co-morbidity and risk. Al-
though many people with CKD go on to
suffer from end-stage renal disease, only 4%
require renal replacement, a much greater
proportion (46%) die from cardiovascular
disease [31]. CKD is diagnosed by measur-
ing renal function. One of the simplest ways
of doing this is to estimate glomerular fil-
tration rate (GFR) from serum creatinine,
age, gender and ethnicity. A GFR of less
than 60 ml/min/1.73 m
2
is diagnostic of
CKD, though the diagnosis can still be made
with a higher (and nearer to normal) GFR
if there is evidence of renal damage.
tioners are generally aware of the evidence-
base for intervention in this condition,
which is set out in national guidance [25].
Many of the general practitioner electronic
patient record systems (EPR) automatically
calculate risk and risk factor calculation
tables are also provided in the standard UK
drug dictionary [26], which is provided free
to all GPs. Data showing the progressive
reduction of cholesterol targets are shown
in Table 2. The standardised prevalence of
IHD recorded in GP computer systems rose
from 3.8% to 4.0%. Cholesterol recording
rose from 47.6% to 89.0% and the mean
cholesterol level fell from 5.18 to
4.67 mmol/L in people with IHD. Mean-
while statin prescribing rose from 49.4%
to 71.5%. The proportion of patients reach-
ing the 5 mmol/L target has improved by
11% each year rising from 46% to 57% to
68% year on year [27]. The intervention
appears to be welcomed by participating
clinicians [28].
Our atrial fibrillation (AF) quality im-
provement programme was the first in
which we calculated risk outside the GP
computer record [9]. We stratified patients
by their level of risk of stroke using evi-
dence-based guidance something our GP
colleagues were not familiar with under-
taking. We found that females received sub-
optimal care because insufficient account
was being taken of their risk of stroke. As in
IHD, we found a higher prevalence of dis-
ease than reported in previous studies. The
age-standardised prevalence of diagnosed
Table 1 Increasing complexity of educational interventions in IHD, AF and CKD
Clinical condition Change in recorded
prevalence
IHD
Ischaemic Heart Disease
Increased 10%
(from 3.8% to 4.2%)
AF
Atrial Fibrillation
Increased 10–15%
Compared with other studies
CKD
Chronic Kidney Disease
Increased 27-fold
Only 3.6% was previously
diagnosed
Practitioner awareness of
evidence-base
Good
National Service Framework
(CHD NSF)
Good
Good awareness of evidence
in literature
Poor
No literature but experience
is GPs are distressed by their
lack of knowledge
Risk calculation
Widely available
Within GP EPR
In standard drug dictionary
(BNF)
Outside GP system by
PCDQ
Outside GP systems by
PCDQ
Implementation of
guidance
Some scope for
improvement
Context of on-going
improvement
Considerable scope for
improvement
Little evidence of any
systematic implementation
of guidance
Complexity of change
required
+ Routine
Recognition still a gap in
quality of care
++ Moderate
Not stratifying by risk, large
proportion scope to improve
care
+++ High
Learn evidence Large number
of undiagnosed and
suboptimally managed
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One quarter of the population (25.7%;
28,862/112,215) had a serum creatinine rec-
orded in their computer record enabling us
to calculate their GFR. One in five (18.9%)
had a GFR <60 ml/min/1.73 m
2
, which is
diagnostic of CKD. This represents 4.9% of
the population. Three-quarters (74.6%;
4,075/5,449) of those with CKD had one
or more circulatory diseases and risk
factors amenable to intervention in pri-
mary care. For example: The mean systolic
blood pressure in those with a normal
GFR was 130 mmHg while for those with a
GFR <60 ml/min/1.73 m
2
systolic BP was
142 mmHg. One-way analysis of variance
shows that the differences were significant
at the p <0.001 level. Evidence-based guid-
ance recommends lowering BP in CKD to
130 mmHg. Similarly, people with diabetes
and CKD were more obese, mean body
mass index was 30 kg/m
2
compared with
those without CKD where it was 27 kg/m
2
.
There is considerable scope for intervention
and improvement of risk factors. Only 3.6%
of these people were recorded as having
renal disease within the GP computer
record. A subsequent hand-search of 500
records in one practice suggested the com-
puter results were reliable with only four
more cases having an indication that they
had CKD only in their written records (i.e.
not transferred into the computer record.)
Primary care professionals involved in
the CKD programme had four challenges:
GPs had no idea that the prevalence of CKD
was so high (5%); they were not familiar
cal records, which accurately reflect the
quality of care.This is particularly important
in England where we are moving towards an
integrated healthcare computer system, with
data entered in one part of the health service
being accessible in another [34]. Feedback
of routinely collected data, in an educational
context, has a place in the tools available to
raise data quality and the quality of clinical
care. The PCDQ audit-based educational ap-
proach provides a working model of such an
intervention.
Although general practice computer data
are becoming more readily available they
have limitations [4, 5, 20]. The wider chal-
lenges of working with every more accessi-
ble clinical data are well described [35].
Specifically, with general practice data
there are: problems with the denominator,
which is known to be inflated [36]; data are
inevitably incomplete for a variety of rea-
sons and missing data requires careful inter-
pretation. Other factors can also improve
data quality, for example: financial incen-
tive; reducing the number of different com-
puter systems that practitioners use [37];
and looking to achieve more standardisation
in the approach to managing conditions.
Although we have not tested this inter-
vention with and without comparative feed-
back between practices, our perception is
that this is also a powerful motivator for
change. A randomised controlled trial has
shown that feedback has been more effec-
tive than just information in the manage-
ment of hypertension [38]. It is likely that
with the evidence-base; the stratification of
risk took place outside the computerised
medical record using a method with which
they were unfamiliar; and they were found
lacking in implementing best practice. Part
of the reason we undertook the hand-search
of 500 records was to generate evidence to
overcome the cognitive dissonance of GPs
that such a large number of people might
have undiagnosed CKD.
Discussion
Improvements in data quality and the capac-
ity and capability of information and com-
munications technologies mean that pro-
gressively more use can be made of routinely
collected general practice computer data. We
are able to achieve ever more complex pro-
cessing of routinely collected data including
manipulating large and complex datasets
outside the GP computer system. These data
can be used to identify high-risk groups and
be used by practitioners to improve the
quality of care in IHD, AF and CKD. How-
ever, for health services to derive more bene-
fit from this data our assertion is that there
needs to be an accompanying educational
programme. Education provides the right
non-judgmental medium through which
clinicians can readily engage in quality im-
provement. Focussing on data quality along-
side the quality of care enables primary care
to work towards having computerised medi-
Table 2 Progressive improvement in cholesterol management in people with ischaemic heart disease in the PCDQ programme
Cholesterol recorded
2002
N (%)
0-24 10
25-44 708 (45.7)
45-64 13,725 (56.1)
65-84 26,630 (49.5)
>85 1,470 (15.3)
All 42,533 (47.6)
2003
N (%)
0 (0.0)
110 (41.4)
2,764 (72.7)
6,953 (72.8)
602 (33.5)
10,429 (67.6)
2004
N (%)
3 (11.1)
269 (74.9)
5360 (92.3)
11,738 (91.7)
1,330 (65.5)
18,700 (89.0)
P
* T-test mpares previous year
** Chi-square compares proportionCo taking a statin with the previous year
Cholesterol value
2002
mean (SD)
5.89 (2.18)
5.23 (1.32)
5.16 (1.15)
5.18 (1.16)
5.55 (1.23)
5.18 (1.71)
2003
mean (SD)
–
5.05 (1.23)
4.98 (1.10)
4.86 (1.08)
5.25 (1.28)
4.91 (1.10)
p <0.001*
2004
mean (SD)
4.77 (1.31)
4.92 (1.22)
4.72 (1.01)
4.62 (1.00)
4.91 (1.15)
4.67 (1.02)
p <0.001*
Taking a statin
2002
N (%)
5 (50.0)
334 (47.2)
7171 (52.2)
13,028 (48.9)
450 (30.6)
20,987 (49.4)
2003
N (%)
0 (0.0)
132 (49.6)
2,917 (76.7)
6,707 (70.3)
544 (30.2)
10,300 (66.7)
p <0.001**
2004
N (%)
1 (3.7)
225 (62.7)
4,690 (80.8)
9,447 (73.8)
671 (33.1)
15,034 (71.5)
p <0.001**
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the lessons from this study are transferable
to other cardiovascular diseases. The rise in
statin prescription in the PCDQ populations
was larger than that reported in the Health-
wise II study, which principally provided
clinical assessment without education [39].
49% were treated on statins at the start of
Healthwise rising to 57% compared with a
rise from the same starting point with
PCDQ from 49.4% to 71.5%, though we ac-
cept our study has taken place over a longer
period with more iterations. As with many
interventions it has not been fully or system-
atically evaluated [40].
Clearly, other factors are important in
using computerised systems to improve the
quality of care many of which are recog-
nised internationally [41]. These include or-
ganisational factors, which include: the use
of financially incentivised quality targets;
improving technical issues like the coding
interface within clinical systems; standard-
ising the coding system; and the motivation
and technical ability of the primary care
clinician to code data. More research is
needed to explore the relative effectiveness
and cost-effectiveness of different types of
intervention.
Conclusions
The PCDQ programme has demonstrated
effectiveness in improving the management
of IHD and in finding people in AF and with
CKD at increased cardiac risk. Feedback in
an educational context, underpinned by a
highly developed technical process provides
the necessary synergy to promote quality
improvement.
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